|
|
Volumn 89, Issue , 2000, Pages 153-179
|
|
Tomorrow's anticancer agents: inhibitors of Ras farnesylation.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
P21(RAS) FARNESYL PROTEIN TRANSFERASE;
P21(RAS) FARNESYL-PROTEIN TRANSFERASE;
RAS PROTEIN;
TRANSFERASE;
ANIMAL;
APOPTOSIS;
CELL DIVISION;
CHEMISTRY;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG EFFECT;
DRUG SCREENING;
HUMAN;
METABOLISM;
NEOPLASM;
PROTEIN PROCESSING;
REVIEW;
SIGNAL TRANSDUCTION;
ALKYL AND ARYL TRANSFERASES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL DIVISION;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
ENZYME INHIBITORS;
HUMANS;
NEOPLASMS;
PROTEIN ISOPRENYLATION;
RAS PROTEINS;
SIGNAL TRANSDUCTION;
MLCS;
MLOWN;
|
|
EID: 0033641479
PISSN: 1023294X
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-0348-8393-1_10 Document Type: Review |
|
Times cited : (3)
|
|
References (98)
|
